.png)
A NEW ERA OF MEDICAL DISCOVERY
The AI-epigenetics platform for clinical care and diagnostics.
Infinite Epigenetics pairs one of the world's largest epigenetic datasets with a proprietary biological AI foundation model — redefining how disease is predicted, detected, and prevented.
Get in Touch
.png)
THE OPERATING SYSTEM OF THE BODY
Where AI, epigenetics, and healthspan converge.
Every test measures more than one million epigenetic signals providing a real-time readout of the body’s health and future risk. Our AI model is trained on one of the world’s largest epigenetic datasets to read these data points with extreme precision.
CLINICAL APPLICATIONS
The AI model that reads the language of biology.
The Infinite platform is a proprietary biological AI model that flags disease years early, predicts who responds to a drug, and measures aging, each a specialized application running on one shared model. The model becomes sharper with every test it reads.
Early disease detection
Prevention years before symptoms appear
Biological age & longevity
Protocols for optimal healthspan
Treatment response
Predict responders before trial-and-error
Mental health
Neurocognitive and nervous system markers
Fertility & maternal
Preconception, IVF, pregnancy,
postpartum
postpartum
Drug discovery & targets
Signatures that reveal what to target
Trial enrichment
Select patients by biology, not diagnosis
code
code
The Foundation
One biological foundation model, with a roadmap to multi-omic inputs
Every disease leaves a signal. We find what others can’t.
Most tests read 50 biological markers. We read over 1 million, each shifting in real time with your body, providing the highest-resolution view of what's happening inside you, years before symptoms appear.
Chronic diseases cause ~75% of deaths worldwide
For the first time, we have combined epigenetics and AI to better predict disease and save millions of lives.
>4 Billion
People worldwide have 1 of these 4 diseases.
- Type 2 Diabetes
- Cardiovascular Disease
- MASLD (Fatty Liver)
- Chronic Obstructive Pulmonary Disease
>7 Years
Average time from disease onset to diagnosis.
$500B
Saved by diagnosing better and earlier.
Infinite Epigenetics is diagnostics reimagined.
Traditional diagnostics are broken. The clinical tools available to diagnose disease are reactive, expensive, and inconvenient. Until now.
Proprietary Algorithms & AI
Owned and validated algorithms developed with top researchers
Improving exponentially via AI, deepening predictive power over time
Predictive & Preventative
Detects and predicts disease before clinical symptoms arise
Initially focused on the top diseases affecting 4B+ people worldwide
Radically Affordable & Scalable
Measures millions of health markers from just a few drops of blood
Yields 20x the value of a traditional lab test’s results
THE INFINITE PORTFOLIO
One platform. Infinite applications.
Infinite Epigenetics powers a clinical diagnostics and longevity solutions with one biological data engine. Every test that TruDiagnostic and Tally runs feeds the same model — so the whole platform gets smarter, and more valuable, over time.
OPERATING COMPANY · CLINICAL
.png)
A commercial diagnostics platform and methylation data engine, TruDiagnostic has processed 120,000+ epigenetic tests, secured multiple active PLA-coded diagnostics, and supported 80+ research studies and trials with pharma and academic partners.
120k+ TESTS
50+ PUBLICATIONS
80+ PARTNERSHIPS
OPERATING COMPANY · CONSUMER
Co-founded by Dr. David Sinclair, a Harvard Medical School professor, Tally is a consumer longevity and biological-age testing company with 15+ peer-reviewed publications validating the science. Built for anyone trying to slow aging and improve healthspan.
TIME-SEQ
15+ PUBLICATIONS
TALLYAGE™
50+ Peer-Reviewed Publications
with Pharma, Academic &
Life Science Partners
.png)
.png)
.png)
.png)
.png)
Developed with the top minds in science
37
MD + PHDs
Who worked on the science behind Infinite Epigenetics
80+
Research partnerships
With leading universities like Harvard, Yale, and Duke
6T+
Human Data Points
Analyzed and used to create Infinite algorithms
1M+
DNA SITES
Measured in every test, giving you the most precise health insights
Jessica Lasky Su, PhD
.png)
Raghav Sehgal, PhD
.png)
Michael Corley, PhD
.png)
Andrew Teschendorff, PhD
.png)
Wanding Zhou, PhD
Helen Messier, MD, PhD
.png)
Sanjeev Goel, MD, FCFP (PC), CAFCI
.png)
Vincent C. Giampapa, MD, FACS
.png)
Edwin Lee, MD, FACE
.png)
Pamela W. Smith, MD, MPH, MS
.png)
Darshan Shah, MD
.png)
Marcos de Andrade, MD, MBA
.png)
Jeffrey Gladden, MD, FACC
.png)
Paul Savage, MD, FACEP, FAARM
.png)
Joseph Raffaele, MD
LEADERSHIP
Founded by the people who built the field of epigenetic intelligence
Founders, scientists, and operators who have built, scaled, and exited category-defining companies with $20B+ in combined exits, 10+ companies founded, 50+ peer-reviewed studies.
FOUNDERS
FOUNDERS
Matt Dawson, MD
Co-Founder & CEO
6× founder; leader in precision medicine and AI in healthcare.
.png)
FOUNDER
Mike Mallin, MD
Co-Founder & Chief Science Officer
2× healthcare founder; 40+ peer-reviewed publications.
.png)
FOUNDERS
Brad Keywell
Co-Founder & Board Member
Founding investor, Tempus AI; multiple $B exits.
.png)
Anastasia Medytska
President
.png)
Chris Walker
Chief Technology Officer
.png)
Katherine Gruneisen
EVP of Marketing
.png)
Jon Terenzetti
EVP of Payor Solutions
.png)
Gaylord VanGuilder
EVP of Healthcare Provider Sales
.png)
Jamie Kennedy
EVP of Operations, Compliance, & Governance
.png)
Melanie Goldey
CEO, Tally Health
.png)
Barrett Block
General Counsel
.png)
Brenda deGerald
VP of Commercial Development
.png)
Loren Clarke
VP of Medical Affairs
Infinite Epigenetics is disrupting a $90 billion market
Infinite Epigenetics
Grail
Delfi
Cologuard
Published Algorithms
Types of Analysis
Methylation & Polygenic
Methylation
Genetic
Methylation & Mutation
Data Testing Size
(CpGs + SNPs)
1,000,000+
Not Published
Not Published
11
Number of
Biomarker Outputs
180+
50
1
1
Collection Type
Blood & Saliva
Blood
Blood
Stool